Sanofi says Lyxumia diabetes drug studies positive
PARIS (Reuters) – Sanofi’s Lyxumia experimental diabetes treatment can slow down the rate at which food passes and can reduce blood sugar levels after a meal when given in combination with other diabetes drugs, the drugmaker said in a statement on Tuesday. Lyxumia is one of several new medicines Sanofi is banking on to drive growth after patent losses on former top-selling drugs. The data from late-stage studies were presented at the European Association for the Study of Diabetes (EASD) congress in Berlin. . . .
View full post on Health News Headlines – Yahoo! News
Leave a Reply